p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c‐Kit activity

It has recently been proposed that defective differentiation of mammary luminal progenitors predisposes to basal‐like breast cancer. However, the molecular and cellular mechanisms involved are still unclear. Here, we describe that the adaptor protein p130Cas is a crucial regulator of mouse mammary epithelial cell (MMEC) differentiation. Using a transgenic mouse model, we show that forced p130Cas overexpression in the luminal progenitor cell compartment results in the expansion of luminal cells, which aberrantly display basal cell features and reduced differentiation in response to lactogenic stimuli. Interestingly, MMECs overexpressing p130Cas exhibit hyperactivation of the tyrosine kinase receptor c‐Kit. In addition, we demonstrate that the constitutive c‐Kit activation alone mimics p130Cas overexpression, whereas c‐Kit downregulation is sufficient to re‐establish proper differentiation of p130Cas overexpressing cells. Overall, our data indicate that high levels of p130Cas, via abnormal c‐Kit activation, promote mammary luminal cell plasticity, thus providing the conditions for the development of basal‐like breast cancer. Consistently, p130Cas is overexpressed in human triple‐negative breast cancer, further suggesting that p130Cas upregulation may be a priming event for the onset of basal‐like breast cancer. STEM Cells2013;31:1422–1433

[1]  L. Trusolino,et al.  Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer , 2013, Oncogene.

[2]  Francesca Orso,et al.  p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells , 2012, Breast Cancer Research.

[3]  C. Caldas,et al.  Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland , 2012, Breast Cancer Research.

[4]  L. Rönnstrand,et al.  Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.

[5]  Yibin Kang,et al.  Elf5 Regulates Mammary Gland Stem/Progenitor Cell Fate by Influencing Notch Signaling , 2012, Stem cells.

[6]  H. Park,et al.  FoxM1 regulates mammary luminal cell fate. , 2012, Cell reports.

[7]  Wenjun Guo,et al.  Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.

[8]  B. Groner,et al.  c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer , 2012, Oncogene.

[9]  C. Perou,et al.  The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium , 2011, Proceedings of the National Academy of Sciences.

[10]  M. Glukhova,et al.  The mammary myoepithelial cell. , 2011, The International journal of developmental biology.

[11]  E. Golemis,et al.  NEDD9 and BCAR1 Negatively Regulate E-Cadherin Membrane Localization, and Promote E-Cadherin Degradation , 2011, PloS one.

[12]  J. Visvader,et al.  Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit , 2011, Oncogene.

[13]  P. Provero,et al.  p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. , 2011, European journal of cell biology.

[14]  E. Lander,et al.  Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. , 2011, Cell stem cell.

[15]  V. Cryns,et al.  Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. , 2011, Molecular endocrinology.

[16]  M. Pegram,et al.  Triple negative breast cancer: unmet medical needs , 2011, Breast Cancer Research and Treatment.

[17]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[18]  P. Defilippi,et al.  Integrin signalling adaptors: not only figurants in the cancer story , 2010, Nature Reviews Cancer.

[19]  David R. Croucher,et al.  Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. , 2010, Cancer research.

[20]  G. Forni,et al.  p130Cas is an essential transducer element in ErbB2 transformation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Ashworth,et al.  BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.

[22]  C. Brisken,et al.  Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates , 2010, Cell Death and Differentiation.

[23]  E. Golemis,et al.  CAS proteins in normal and pathological cell growth control , 2010, Cellular and Molecular Life Sciences.

[24]  J. Visvader,et al.  Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. , 2009, Genes & development.

[25]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[26]  S. Sinha,et al.  An Active Role of the ΔN Isoform of p63 in Regulating Basal Keratin Genes K5 and K14 and Directing Epidermal Cell Fate , 2009, PloS one.

[27]  J. Stingl Detection and analysis of mammary gland stem cells , 2009, The Journal of pathology.

[28]  M. Zvelebil,et al.  Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate , 2008, BMC Genomics.

[29]  J. Visvader,et al.  Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. , 2008, Cell stem cell.

[30]  Z. Werb,et al.  GATA-3 and the regulation of the mammary luminal cell fate. , 2008, Current opinion in cell biology.

[31]  A. Welm,et al.  Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. , 2008, Cell stem cell.

[32]  M. Smalley,et al.  Prospective Isolation and Functional Analysis of Stem and Differentiated Cells from the Mouse Mammary Gland , 2007, Stem Cell Reviews.

[33]  M. Cole,et al.  Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. , 2007, Cancer research.

[34]  A. Ashworth,et al.  Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland , 2007, The Journal of cell biology.

[35]  C. Eaves,et al.  Deciphering the Mammary Epithelial Cell Hierarchy , 2006, Cell cycle.

[36]  A. Sapino,et al.  Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure , 2006, Virchows Archiv.

[37]  A. Sapino,et al.  p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. , 2006, Cancer research.

[38]  Paola Defilippi,et al.  p130Cas: a versatile scaffold in signaling networks. , 2006, Trends in cell biology.

[39]  Haiyan I. Li,et al.  Purification and unique properties of mammary epithelial stem cells , 2006, Nature.

[40]  A. Ashworth,et al.  CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells , 2005, Breast Cancer Research.

[41]  R. Roskoski Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor. , 2005, Biochemical and biophysical research communications.

[42]  A. Ashworth,et al.  Hallmarks of 'BRCAness' in sporadic cancers , 2004, Nature Reviews Cancer.

[43]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[44]  K. Wilson,et al.  Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase* , 2004, Journal of Biological Chemistry.

[45]  C. Watson,et al.  A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland , 2000, Breast Cancer Research.

[46]  M. O'hare,et al.  Differentiation of Separated Mouse Mammary Luminal Epithelial and Myoepithelial Cells Cultured on EHS Matrix Analyzed by Indirect Immunofluorescence of Cytoskeletal Antigens , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  J. Groopman,et al.  Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis. , 1998, Journal of immunology.

[48]  J. Visvader,et al.  Delineating the epithelial hierarchy in the mouse mammary gland. , 2008, Cold Spring Harbor symposia on quantitative biology.

[49]  G. Sauter,et al.  KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  M. Loda,et al.  Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. , 2002, Cancer research.